0001209191-17-022143.txt : 20170321 0001209191-17-022143.hdr.sgml : 20170321 20170321204335 ACCESSION NUMBER: 0001209191-17-022143 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170317 FILED AS OF DATE: 20170321 DATE AS OF CHANGE: 20170321 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc. CENTRAL INDEX KEY: 0001557746 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460571712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SUITE 400, 101 LINDENWOOD DRIVE CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-321-5554 MAIL ADDRESS: STREET 1: SUITE 400, 101 LINDENWOOD DRIVE CITY: MALVERN STATE: PA ZIP: 19355 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Molineaux Christopher P. CENTRAL INDEX KEY: 0001654773 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37581 FILM NUMBER: 17705353 MAIL ADDRESS: STREET 1: C/O ACLARIS THERAPEUTICS, INC. STREET 2: 101 LINDENWOOD DRIVE, SUITE 400 CITY: MALVERN STATE: PA ZIP: 19355 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-03-17 0 0001557746 Aclaris Therapeutics, Inc. ACRS 0001654773 Molineaux Christopher P. C/O ACLARIS THERAPEUTICS, INC. 101 LINDENWOOD DRIVE, SUITE 400 MALVERN PA 19355 1 0 0 0 Common Stock 2017-03-17 4 M 0 6702 0.41 A 6702 D Common Stock 2017-03-17 4 M 0 592 1.52 A 7294 D Common Stock 2017-03-17 4 M 0 311 0.72 A 7605 D Stock option (right to buy) 0.41 2017-03-17 4 M 0 6702 0.00 D 2024-01-28 Common Stock 6702 1993 D Stock option (right to buy) 1.52 2017-03-17 4 M 0 592 0.00 D 2024-12-07 Common Stock 592 462 D Stock option (right to buy) 0.72 2017-03-17 4 M 0 311 0.00 D 2024-08-12 Common Stock 311 171 D 25% of the shares underlying this option vested on January 29, 2015 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the reporting person's continued service with the Issuer as of the applicable vesting date. 25% of the shares underlying this option vested on December 8, 2015 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the reporting person's continued service with the Issuer as of the applicable vesting date. 25% of the shares underlying this option vested on August 13, 2015 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the reporting person's continued service with the Issuer as of the applicable vesting date. /s/ Brian F. Leaf, attorney-in-fact 2017-03-21